Penile Carcinoma clinical trials
13 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)
- Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
- Human Penile Allotransplantation
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
- Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
- Urologic Lymphadenectomy in AMIGO
- A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- Integrated Cancer Repository for Cancer Research
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Penile Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.